相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives
Lim Ju Yin et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs
Xiaoan Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
Anna Tashchilova et al.
MOLECULES (2022)
Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review
Jacek Szczepanski et al.
MOLECULES (2022)
The Importance of Rhodanine Scaffold in Medicinal Chemistry: A Comprehensive Overview
Arif Mermer
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Harish C. Upadhyay
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation
Rameshwari Verma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Novel Hybrid Molecules Based on triazole-β-lactam as Potential Biological Agents
Pezhman Shiri
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Antitubercular properties of thiazolidin-4-ones - A review
Nazar Trotsko
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
α-Glucosidase, α-Amylase Inhibition, Kinetics and Docking Studies of Novel (2-Chloro-6-(trifluoromethyl)benzyloxy)arylidene) Based Rhodanine and Rhodanine Acetic Acid Derivatives
Vasantha Kumar et al.
CHEMISTRYSELECT (2021)
Drug screening of rhodanine derivatives for antibacterial activity
Suresh Maddila et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
New N-ribosides and N-mannosides of rhodanine derivatives with anticancer activity on leukemia cell line: Design, synthesis, DFT and molecular modelling studies
Ahmed Khodair et al.
CARBOHYDRATE RESEARCH (2020)
Innovative Three-Step Microwave-Promoted Synthesis of N-Propargyltetrahydroquinoline and 1,2,3-Triazole Derivatives as a Potential Factor Xa (FXa) Inhibitors: Drug Design, Synthesis, and Biological Evaluation
Fabian Santana-Romo et al.
MOLECULES (2020)
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
Nadezhda Novichikhina et al.
MOLECULES (2020)
Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review
Parteek Prasher et al.
DRUG DEVELOPMENT RESEARCH (2020)
Navigating the Synthesis of Quinoline Hybrid Molecules as Promising Anticancer Agents
Pravati Panda et al.
CHEMISTRYSELECT (2020)
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Prashant S. Auti et al.
RSC ADVANCES (2020)
Synthesis of Novel Fluorine Compounds Substituted-4-thiazolidinones Derived from Rhodanine Drug as Highly Bioactive Probes
Mohammad S. T. Makki et al.
CURRENT ORGANIC SYNTHESIS (2019)
Fluorogenic D-amino acids enable real-time monitoring of peptidoglycan biosynthesis and high-throughput transpeptidation assays
Yen-Pang Hsu et al.
NATURE CHEMISTRY (2019)
A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities
Seyyed Mojtaba Mousavi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Viktoriya Ivasiv et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling
Ivan Ilin et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Design and synthesis of biaryloxazolidinone derivatives containing a rhodanine or thiohydantoin moiety as novel antibacterial agents against Gram-positive bacteria
Yachuang Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Hybrid Molecules Development: A Versatile Landscape for the Control of Aritifungal Drug Resistance: A Review
Chioma G. Anusionwu et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors
Zilun Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors
Hong Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Factor XIa Inhibitors as New Anticoagulants
Mimi L. Quan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Jiachun Liu et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Synthesis, Docking, and Anticoagulant Activity of New Factor-Xa Inhibitors in a Series of Pyrrolo[3,2,1-ij]Quinoline-1,2-Diones
S. M. Medvedeva et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2018)
Hybrid organic molecules as antiinflammatory agents; a review of structural features and biological activity
Noor ul Amin Mohsin et al.
TURKISH JOURNAL OF CHEMISTRY (2018)
Recent developments with rhodanine as a scaffold for drug discovery
Danylo Kaminskyy et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Discovery of a Parenteral Small Molecule Coagulation Factor Xla Inhibitor Clinical Candidate (BMS-962212)
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
INFLUENCE OF THE METHOD OF HYDROGEN ATOMS INCORPORATION INTO THE TARGET PROTEIN ON THE PROTEIN-LIGAND BINDING ENERGY
D. C. Kutov et al.
BULLETIN OF THE SOUTH URAL STATE UNIVERSITY SERIES-MATHEMATICAL MODELLING PROGRAMMING & COMPUTER SOFTWARE (2017)
New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study
Mostafa M. M. El-Miligy et al.
BIOORGANIC CHEMISTRY (2017)
Effects of 8-halo-7-deaza-2′-deoxyguanosine triphosphate on DNA synthesis by DNA polymerases and cell proliferation
Yizhen Yin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group
James R. Corte et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Novel tetrazoloquinoline-rhodanine conjugates: Highly efficient synthesis and biological evaluation
Dnyaneshwar D. Subhedar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Hybrid molecules: The privileged scaffolds for various pharmaceuticals
Shaveta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of novel pyrazole-rhodanine hybrid scaffolds as potent inhibitors of aldose reductase: design, synthesis, biological evaluation and molecular docking analysis
Hina Andleeb et al.
RSC ADVANCES (2016)
From hybrid compounds to targeted drug delivery in antimalarial therapy
Rudi Oliveira et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Pyridine and pyridinone-based factor XIa inhibitors
James R. Corte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors
Mei-Lin Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa
Pancras C. Wong et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)
Application of Molecular Modeling to Development of New Factor Xa Inhibitors
Vladimir B. Sulimov et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design
Ola Fjellstrom et al.
PLOS ONE (2015)
Rational design of small molecules targeting the C2 domain of coagulation factor VIII
Gerry A. F. Nicolaes et al.
BLOOD (2014)
New Heterocyclic Systems Based on Substituted 3,4-Dihydro-1H-Spiro[Quinoline-2,1'-Cycloalkanes]
S. M. Medvedeva et al.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2014)
Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery
Markus O. Zimmermann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors
Mimi L. Quan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents
Meng Guo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Application of the Docking Program SOL for CSAR Benchmark
Alexey V. Sulimov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
Thomas Mendgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
Marcus D. Hanwell et al.
JOURNAL OF CHEMINFORMATICS (2012)
Observations on screening-based research and some concerning trends in the literature
Jonathan B. Baell
FUTURE MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Rhodanine as a Privileged Scaffold in Drug Discovery
T. Tomasic et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with biaryl P4 motifs
Robert J. Young et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties
Michael Decker
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
分享论文
